Merck Receives FDA Approval for Ebola Vaccine

upstart writes in with an IRC submission for chromas:

Merck receives FDA approval for Ebola vaccine:

The U.S. Food and Drug Administration said on Thursday it approved drugmaker Merck & Co's (MRK.N) Ebola vaccine Ervebo, making it the first FDA-authorised vaccine against the deadly virus.

The vaccine was used by the World Health Organization and Democratic Republic of the Congo as an investigational vaccine to help reduce Ebola virus disease (EVD) outbreaks in few West African countries from 2014 to 2016.

[...] The vaccine, which is administered as a single-dose injection, will help to prevent EVD caused by Zaire ebolavirus in patients aged 18 years and older, the regulator said in a statement.

Original Submission

Read more of this story at SoylentNews.